Hannah joseph hospital Limited has fulfilled its quarterly compliance requirements by submitting a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The healthcare provider, which operates as an institute specializing in neurosciences, cardiac sciences, orthopaedics and traumatology, filed the necessary documentation with BSE Limited on April 09, 2026.

Regulatory Compliance Details

The certificate was issued by BTS Consultancy Services Private Limited, serving as the company's Registrar and Share Transfer Agents. The document confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 is not applicable to Hannah Joseph Hospital Limited, as the entire holding of the company's equity shares are maintained in demat form.

Company Information

Hannah Joseph Hospital Limited operates with its registered office located at 134, Lake View Road, K.K.Nagar, Madurai - 625 020, Tamil Nadu. The company's corporate office is situated at R.S. No: 115/3B2 116/1A2, Madurai-Tuticorin Ring Road, Chinthamani, Madurai - 625 009, Tamil Nadu. The healthcare facility holds NABH accreditation and operates NABL accredited laboratories.

Compliance Framework

The submission was signed by CS Yuvaraj Saravanan, Company Secretary & Compliance Officer, who holds ICSI Membership No.: A66149. The digital signature was applied on April 09, 2026, at 14:23:27 +05'30'. This quarterly filing represents part of the company's ongoing regulatory compliance obligations under SEBI guidelines for listed entities.

The certificate from BTS Consultancy Services confirms the company's adherence to modern share holding practices, with all equity shares maintained in electronic format through the depository system, eliminating the need for physical share certificates and ensuring efficient transfer mechanisms.

Hannah Joseph Hospital Limited has announced that Dr. Natarajan Arunkumar, a designated person and senior management personnel of the company, has acquired 26,000 equity shares through multiple market transactions. The disclosure was made to BSE Limited on April 06, 2026, in compliance with SEBI insider trading regulations.

Share Acquisition Details

Dr. Natarajan Arunkumar completed the share acquisition through three separate transactions conducted over a two-month period. The purchases were executed on the BSE through on-market transactions with a combined value of Rs. 16,19,420.

Transaction Breakdown

The acquisition was structured across three separate purchase dates, demonstrating a systematic approach to building the equity position.

Shareholding Position

Following the completion of these transactions, Dr. Arunkumar's total shareholding in Hannah Joseph Hospital Limited has increased significantly. His updated position reflects a notable increase in both absolute share count and percentage ownership.

Regulatory Compliance

The company received the disclosure from Dr. Natarajan Arunkumar on April 01, 2026, pursuant to Regulation 7(2)(a) of the SEBI Insider Trading Regulations. Hannah Joseph Hospital Limited subsequently informed BSE Limited on April 06, 2026, fulfilling its obligations under Regulation 7(2)(b) of the same regulations. The disclosure was submitted in the prescribed Form C format, providing comprehensive details of the transactions including dates, quantities, and transaction values.

Company Information

Hannah Joseph Hospital Limited operates as a healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company is listed on BSE with scrip code 544687 and trades under the symbol HANNAH. The hospital maintains NABH accreditation and operates from its corporate office in Madurai, Tamil Nadu.